Dissociation of P2 purinoceptor-mediated increase in intracellular Ca2+ level from myosin light chain phosphorylation and contraction in rat aorta

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 543-548

  Kitajima, Satoshi ^a   Harada, Ken Ichi ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a   Karaki, Hideaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATP; Cytosolic Ca2+ level; Force; P2 purinoceptors; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; MYOSIN LIGHT CHAIN; PURINE RECEPTOR; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM ION; NORADRENALIN; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL; AORTA; ARTICLE; DRUG EFFECT; MALE; METABOLISM; MUSCLE CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY; RAT; TIME; WISTAR RAT; ANIMAL TISSUE; AORTA MEDIA; ARTERY CONSTRICTION; CALCIUM CELL LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; CALCIUM; MALE; MUSCLE CONTRACTION; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; TIME FACTORS;

EID: 0029658959     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15436.x     Document Type: Article

References (33)

1. ABBRACCHIO, M.P., CATTABENI, F., FREDHOLM, B.B. & WILLIAMS, M. (1993). Purinoceptor nomenclature: a status report, Drug Develop. Res., 28, 207-213.
2. 2+ level and contraction in vascular smooth muscle. J. Pharmacol. Exp. Ther., 249, 895-900.
3. 2+ channel activated by ATP in smooth muscle. Nature, 328, 275-278.
4. BURNSTOCK, G. (1993). Physiological and pathological roles of purines: an update. Drug Develop. Res., 28, 195-206.
5. 2-purinoceptor? Gen. Pharmacol. 16, 433-440.
6. CHEN, Q. & VAN BREEMEN, C. (1993) The superficial buffer barrier in venous smooth muscle: sarcoplasmic reticulum refilling and unloading. Br. J. Pharmacol., 109, 336-343.
7. DORN, G.W.-II, BECKER, M.W. & DAVIS, G. (1992). Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J. Biol. Chem., 267, 24897-24905.
8. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
9. EL-MOATASSIM, C., DORNAND, J. & MANI, J. (1992). Extracellular ATP and cell signalling. Biochim. Biophys. Acta., 1134, 31-45.
10. ERLINGE, D., YOO, H., EDVINSSON, L., REIS, D.J. & WAHLESTEDT, C. (1993). Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol., 265, H1089-H1097.
11. GORDON, J.L. (1986). Extracellular ATP: effects, sources and fate. Biochem. J., 323, 309-319.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3340-3450.
13. 2+ in cultured smooth muscle cells. Am. J. Physiol., 263, C95-C105.
14. KAMM, K.E. & STULL, J.T. (1985). The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol., 25, 593-620.
15. 2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol. Sci., 10, 320-325.
16. KARAKI, H., KUBOTA, H. & URAKAWA, N. (1979). Mobilization of stored calcium for phasic contraction induced by norepinephrine in rabbit aorta. Eur. J. Pharmacol., 56, 237-245.
17. 2 purinoceptors in the isolated rabbit central ear artery. Blood Vessels, 22, 145-155.
18. 2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur. J. Pharmacol., 107, 161-168.
19. 2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br. J. Pharmacol., 115, 177-185.
20. 2+ level and force in rat isolated aorta. Br. J. Pharmacol., 110, 263-268.
21. 2+ levels in rat aortic smooth muscle. Eur. J. Pharmacol. Mol. Pharmacol., 266, 263-267.
22. KONISHI, M., OLSON, A., HOLLINGWORTH, S. & BAYLOR, S.M. (1988). Myoplasmic binding of fura-2 investigated by steady state fluorescence and absorbance measurement. Biophys. J., 54, 1089-1104.
23. MALAM-SOULEY, R., CAMPAN, M., GADEAU, A.P. & DESGRANGES, C. (1993). Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am. J. Physiol., 264, C783-C788.
24. NELSON, M.T., CHENG, H., RUBART, M., SANTANA, L.F., BONEV, A.D., KNOT, H.J. & LEDERER, W.J. (1995). Relaxation of arterial smooth muscle by calcium sparkes. Science, 270, 633-637.
25. O'CONNOR, S.E. (1992). Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci., 50, 1657-1664.
26. OLSSON, R.A. & PEARSON, J.D. (1990). Cardiovascular Purinoceptors. Physiol. Rev., 70, 761-849.
27. OZAKI, H., BLONDFIELD, D.P., HORI, M., SANDERS, K.M. & PUBLICOVER, N.G. (1992). Cyclic AMP-mediated regulation of excitation-contraction coupling in canine gastric smooth muscle. J. Physiol., 447, 351-372.
28. OZAKI, H., SATO, K. & KARAKI, H. (1987). Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn. J. Pharmacol., 45, 429-433.
29. i sensitivity of phosphorylation and an unusual form of receptor desensitization in smooth muscle. J. Biol. Chem., 266, 5407-5411.
30. SATO, K., OZAKI, H. & KARAKI, H. (1988). Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura-2. J. Pharmacol. Exp. Ther., 246, 294-300.
31. SATO, K., OZAKI, H. & KARAKI, H. (1990). Differential effects of carbachol on cytosolic calcium levels in vascular endothelium and smooth muscle. J. Pharmacol. Exp. Ther., 255, 114-119, 1990.
32. 2+ in cultured aortic smooth muscle cells. J. Biochem., 104, 795-800.
33. i, myosin light chain phosphorylation, and contraction in human myometrium. Am. J. Physiol., 260, C861-C867.